Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol - United States and Canada, 2001-2005

Morbidity and Mortality Weekly Report

Volumn 54, Issue 29, 2005, Pages 724-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32544442018     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Food and Drug Administration. FDA Public Health Advisory: sepsis and medical abortion. Rockville, Maryland: Food and Drug Administration, Center for Drug Evaluation and Research; 2005. Available at http://www.fda.gov/cder/drug/ advisory/mifeprex.htm.
2. Sinave C, Le Templier G, Blouin D, Leveille F, Deland E. Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. Clin Infect Dis 2002;35:1441-3.
3. McGregor JA, Soper DE, Lovell G, Todd JK. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989;161:987-95.